Date:
Wed, 05 Aug 2026 13:07:03 EDT
Content:
The U.S. Food and Drug Administration (FDA) has released a new regulatory update concerning Zydus Lifesciences Limited, based in Ahmedabad, Gujarat, India.
This update, associated with facility identifier 3012977526, reflects the FDA’s ongoing oversight of international pharmaceutical manufacturing operations. The record follows documentation from May 2026, highlighting the agency’s role in verifying compliance with stringent quality standards and Good Manufacturing Practices (GMP).
As a significant contributor to the global medicine supply, Zydus Lifesciences is subject to regular evaluations to ensure that all exported products meet required safety and efficacy benchmarks. Monitoring such facilities is essential for maintaining the integrity of the healthcare supply chain.
Source: FDA
Link:
http://www.fda.gov/about-fda/zydus-lifesciences-limited
Keywords:
FDA, Zydus Lifesciences, Pharmaceutical Manufacturing, India, Drug Safety, Regulatory Compliance